Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

3.8K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

5.0K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.0K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

6.2K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
6.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

11.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on Mast Cell Proteases as Drug Targets.

Immunology and allergy clinics of North America·2023
Same author

Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms.

Blood advances·2022
Same author

Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2021
Same author

An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma.

Cell·2020
Same author

An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma.

Cell·2019
Same author

Therapeutic targeting of cathepsin C: from pathophysiology to treatment.

Pharmacology & therapeutics·2018

Related Experiment Video

Updated: Apr 12, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

13.1K

Mast cell proteases as pharmacological targets.

George H Caughey1

  • 1Cardiovascular Research Institute, School of Medicine, University of California at San Francisco, CA, United States; Department of Medicine, School of Medicine, University of California at San Francisco, CA, United States; Veterans Affairs Medical Center, San Francisco, CA, United States.

European Journal of Pharmacology
|May 11, 2015
PubMed
Summary

Mast cells release proteases that play roles in both health and disease. Understanding these mast cell proteases is key to developing new therapies for various conditions.

Keywords:
BasophilCarboxypeptidase A3Cathepsin CCathepsin GCathepsin LChymaseDipeptidylpeptidase IMast cellProteaseTryptase

More Related Videos

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.2K
An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.8K

Related Experiment Videos

Last Updated: Apr 12, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

13.1K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.2K
An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.8K

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Mast cells are key immune cells containing potent proteases within their granules.
  • These proteases are released upon mast cell activation and can act locally or systemically.
  • Major mast cell proteases include tryptases, chymases, and various cathepsins, with some being mast cell-specific.

Purpose of the Study:

  • To review the diverse roles of mast cell proteases in health and disease.
  • To highlight the therapeutic potential of targeting mast cell proteases.
  • To discuss the implications of species- and subset-specific protease expression for drug development.

Main Methods:

  • Literature review of mast cell proteases and their functions.
  • Analysis of protease expression patterns in human mast cell subsets and across species.
  • Examination of disease associations and therapeutic strategies involving mast cell proteases.

Main Results:

  • Mast cell proteases are implicated in a wide range of allergic and non-allergic diseases, including asthma, arthritis, and cardiovascular conditions.
  • Some proteases may have protective roles in infections and inflammation.
  • Significant differences exist in protease expression between human mast cell subsets and between humans and other mammals.

Conclusions:

  • Mast cell proteases represent promising therapeutic targets for numerous diseases.
  • Further research into species- and subset-specific differences is crucial for effective drug development.
  • Targeting mast cell proteases offers potential for novel treatments, with considerations for administration routes and specific disease indications.